Congenital hyperinsulinism

Early Human Development

Volumn 86, Issue 5, 2010, Pages 287-294

  Arnoux, Jean Baptiste ^a   de Lonlay, Pascale ^a   Ribeiro, Maria Joao ^f   Hussain, Khalid ^b   Blankenstein, Oliver ^c   Mohnike, Klaus ^d   Valayannopoulos, Vassili ^a   Robert, Jean Jacques ^a   Rahier, Jacques ^e   Sempoux, Christine ^e   Bellanné, Christine ^g   Verkarre, Virginie ^a   Aigrain, Yves ^a   Jaubert, Francis ^a   Brunelle, Francis ^a   Nihoul Fékété, Claire ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Congenital hyperinsulinism; Diffuse; DOPA PET CT; Focal; Potassium channel

Indexed keywords

6 FLUORODOPA F 18; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM ANTAGONIST; DIAZOXIDE; GLUCAGON; GLUCOKINASE; GLUCOSE; GLUTAMATE DEHYDROGENASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROXYACYL COA DEHYDROGENASE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; LEUCINE; MONOCARBOXYLATE TRANSPORTER 1; NIFEDIPINE; OCTREOTIDE; OXIDOREDUCTASE; SOMATOSTATIN DERIVATIVE; SULFONYLUREA RECEPTOR 1; TOLBUTAMIDE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

BECKWITH WIEDEMANN SYNDROME; BLOOD TOXICITY; CELL HYPERPLASIA; CHANNELOPATHY; CHOLELITHIASIS; CHROMOSOME 11P; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DELAYED DIAGNOSIS; DOMINANT INHERITANCE; DRUG ACCUMULATION; DRUG DOSE INCREASE; DRUG SENSITIVITY; EDEMA; FACE DYSMORPHIA; GENE MUTATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HORMONE ACTION; HUMAN; HYPERTRICHOSIS; HYPOGLYCEMIA; IMAGE RECONSTRUCTION; INSULIN RELEASE; KETOGENESIS; LIVER CYTOLYSIS; LIVER TOXICITY; NEUTROPENIA; NEWBORN HYPOGLYCEMIA; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PATHOPHYSIOLOGY; PATIENT POSITIONING; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; RECESSIVE INHERITANCE; REVIEW; SOTOS SYNDROME; THREE DIMENSIONAL IMAGING; TREATMENT INDICATION; COMPLICATION; CONGENITAL HYPERINSULINISM; ENDOCRINE SURGERY; GENETIC DISEASES, INBORN; NEWBORN; PROCEDURES;

ENDOCRINE SURGICAL PROCEDURES; GENETIC DISEASES, INBORN; HUMANS; HYPOGLYCEMIA; INFANT, NEWBORN; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; CONGENITAL HYPERINSULINISM;

EID: 77954029402     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.05.003     Document Type: Review

References (46)

1. Stanley C.A. Hyperinsulinism in infants and children. Ped Clin North Am 1997, 44:363-374.
2. Bruining G.J. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr 1990, 2:758-765.
3. Dunne M.J., Cosgrove K.E., Shepherd R.M., Aynsley-Green A., Lindley K.J. Hyperinsulinism in infancy from basic science to clinical disease. Physiol Rev 2004, 84:239-275.
4. de Lonlay P., Cormier-Daire V., Amiel J., Touati G., Goldenberg A., Fournet J.C., et al. Facial appearance in persistent hyperinsulinemic hypoglycemia. Am J Med Genet 2002, 111:130-133.
5. de Lonlay P., Cuer M., Vuillaumier-Barrot S., Beaune G., Castelnau P., Kretz M., et al. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: a new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. J Pediatr 1999, 135:379-383.
6. Raizen D.M., Brooks-Kayal A., Steinkrauss L., Tennekoon G.I., Stanley C.A., Kelly A. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations. J Pediatr 2005, 146:388-394.
7. Thomas C.G., Underwood L.E., Carney C.N., Dolcourt J.L., Whitt J.J. Neonatal and infantile hypoglycemia due to insulin excess: new aspects of diagnosis and surgical management. Ann Surg 1977, 185:505-517.
8. Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycemia of infancy. Horm Res 2008, 69:2-13.
9. Otonkoski T., Kaminen N., Ustinov J., Lapatto R., Meissner T., Mayatepek E., et al. Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes 2003, 52:199-204.
10. Pearson E.R., Boj S.F., Steele A.M., Barrett T., Stals K., Shield J.P., et al. Macrosomia and hyperinsulinaemic hypoglycemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007, 4:e118.
11. Touati G., Poggi-Travert F., Ogier de Baulny H., Rahier J., Brunelle F., Nihoul-Fekete C., et al. Long-term treatment of persistent hyperinsulinaemic hypoglycemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 1998, 157:628-633.
12. Thornton P.S., Alter C.A., Katz L.E., Baker L., Stanley C.A. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr 1993, 123:637-643.
13. Shilyanski J., Fisher S., Cutz E., Perlman K., Filler R.M. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate?. J Pediatr Surg 1997, 32:342-346.
14. de Lonlay-Debeney P., Poggi-Travert F., Fournet J.C., Sempoux C., Vici C.D., Brunelle F., et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999, 340:1169-1175.
15. Sempoux C., Guiot Y., Lefevre A., Nihoul-Fékété C., Jaubert F., Saudubray J.M., et al. Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 1998, 83:1455-1461.
16. Rahier J., Sempoux C., Fournet J.C., Poggi F., Brunelle F., Nihoul-Fekete C., et al. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycemia: the pathologist's role. Histopathology 1998, 32:15-19.
17. Goossens A., Gepts W., Saudubray J.M., Bonnefont J.P., Nihoul-Fekete, Heitz P.U., et al. Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol 1989, 13:766-775.
18. Rahier J., Fält K., Müntefering H., Becker K., Gepts W., Falkmer S. The basic structural lesion of persistent neonatal hypoglycemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells?. Diabetologia 1984, 26:282-289.
19. Stanley C.A., Thornton P.S., Ganguly A., MacMullen C., Underwood P., Bhatia P., et al. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 2004, 90:189.
20. Giurgea I., Laborde K., Touati G., Bellanné-Chantelot C., Nassogne M.C., Sempoux C., et al. Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism. J Clin Endocrinol Metab 2004, 89:925-929.
21. Otonkoski T., Näntö-Salonen K., Seppänen M., Veijola R., Huopio H., Hussain K., et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 2006, 55:13-18.
22. Ribeiro M.J., De Lonlay P., Delzescaux T., Boddaert N., Jaubert F., Bourgeois S., et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-l-DOPA. J Nucl Med 2005, 46:560-566.
23. Barthlen W., Blankenstein O., Mau H., Koch M., Höhne C., Mohnike W., et al. Evaluation of (18F)FDOPA PET-CT for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab 2008, 93(3):869-875. [Epub 2007 Dec 11].
24. Ribeiro M.J., Boddaert N., Delzescaux T., Valayannopoulos V., Bellanné-Chantelot C., Jaubert F., et al. Functional imaging of the pancreas: the role of [18F]fluoro-l-DOPA PET in the diagnosis of hyperinsulinism of infancy. Endocr Dev 2007, 12:55-66.
25. Hardy O.T., Hernandez-Pampaloni M., Saffer J.R., Suchi M., Ruchelli E., Zhuang H., et al. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr. 2007, 150:140-145.
26. Brunelle F., Negre V., Barth M.O., Fekete C.N., Czernichow P., Saudubray J.M., et al. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989, 19:100-103.
27. Dubois J., Brunelle F., Touati G., Sebag G., Nuttin C., Thach T., et al. Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995, 25:512-516.
28. Delonlay P., Simon A., Galmiche-Rolland L., Giurgea I., Verkarre V., Aigrain Y., et al. Neonatal hyperinsulinism: clinicopathologic correlation. Hum Pathol 2007, 38:387-399.
29. Crétolle C., Fékété C.N., Jan D., Nassogne M.C., Saudubray J.M., Brunelle F., et al. Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycemia in infancy: a report of 45 cases from 1983 to 2000. J Pediatr Surg 2002, 37:155-158.
30. Bax K.N., van der Zee D.C. The laparoscopic approach toward hyperinsulinism in children. Semin Pediatr Surg. 2007, 16:245-251.
31. de Lonlay P., Fournet J.C., Rahier J., Gross-Morand M.S., Poggi-Travert F., Foussier V., et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997, 100:802-807.
32. Verkarre V., Fournet J.C., de Lonlay P., Gross-Morand M.S., Devillers M., Rahier J., et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998, 102:1286-1291.
33. Thomas P.M., Cote G.J., Wohllk N., Haddad B., Mathew P.M., Rabl W., et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995, 268:426-429.
34. Nestorowicz A., Wilson B.A., Schoor K.P., Inoue H., Glaser B., Landau H., et al. Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996, 5:1813-1822.
35. Thomas P., Ye Y., Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996, 5:1809-1812.
36. Nestorowicz A., Inagaki N., Gonoi T., Schoor K.P., Wilson B.A., Glaser B., et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 1997, 46:1743-1748.
37. Huopio H., Otonkoski T., Vauhkonen I., Reimann F., Ashcroft F.M., Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonyllurea receptor 1. Lancet 2003, 361:301-307.
38. Glaser B., Kesavan P., Heyman M., Davis E., Cuesta A., Buchs A., et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998, 338:226-230.
39. Stanley C.A., Lieu Y., Hsu B.Y., Burlina A.B., Greenberg C.R., Hopwood N.J., et al. Hyperinsulinemia and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998, 338:1352-1357.
40. Otonkoski T., Jiao H., Kaminen-Ahola N., Tapia-Paez I., Ullah M.S., Parton L.E., et al. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet. 2007, 81:467-474.
41. Højlund K., Hansen T., Lajer M., Henriksen J.E., Levin K., Lindholm J., et al. A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes 2004, 53:1592-1598.
42. Clayton P.T., Eaton S., Aynsley-Green A., Edginton M., Hussain K., Krywawych S., et al. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 2001, 108:457-465.
43. Mazor-Aronovitch K., Gillis D., Lobel D., Hirsch H.J., Pinhas-Hamiel O., Modan-Moses D., et al. Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur J Endocrinol. 2007, 157:491-497.
44. Hussain K., Blankenstein O., De Lonlay P., Christesen H.T. Hyperinsulinaemic hypoglycemia: biochemical basis and the importance of maintaining normoglycaemia during management. Arch Dis Child 2007, 92:568-570.
45. Menni F., de Lonlay P., Sevin C., Touati G., Peigné C., Barbier V., et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001, 107:476-479.
46. Filan P.M., Inder T.E., Cameron F.J., Kean M.J., Hunt R.W. Neonatal hypoglycemia and occipital cerebral injury. J Pediatr. 2006, 148:552-555.